<unk>  <unk>  is an extremely rare myeloproliferative neoplasms with almost 200 cases in the world. While, most of the time this disease is asymptomatic, fatigue, weight loss, night sweats, bone pain, gout and pruritus are some of its symptoms. Splenomegaly is found in examination of most patients. CSF3R mutations are seen in most patient and is  responsible for pathogenesis of<unk>  patients. World health organization (WHO) introduces criteria for the diagnosis of<unk>  <unk>  that are based on the laboratory finding of peripheral blood cells, bone marrow, cytogenic mutation, and differential diagnosis. There is no treatment for<unk>  <unk> . Although, hematopoitic stem cell transplant, hydroxyurea, interferon, hypomethylating agents, ruxolitinib, thalidomide, cladribine, imatinib, splenic irradiation and splenectomy are some options that are used in patients with<unk> . There is no treatment for<unk>  <unk> . Although, hematopoitic stem cell transplant, hydroxyurea, interferon, hypomethylating agents, ruxolitinib, thalidomide, cladribine, imatinib, splenic irradiation and splenectomy are some options that are used in patients with<unk> .
Chronic neutrophilic leukemia
Prolymphocytic leukemia
Leukemoid reaction
Chronic lymphocytic leukemia
Adult T-cell leukemia
Acute monocytic leukemia
Acute myeloid leukemia
Lymphoid leukemia